I have been studying R&D across industries shows that there are many great lessons that can be leveraged in Pharma R&D. Fundamentally R&D is the management of three things:
- sources of ideas
- sources of funding
- sources of capability to bring the ideas to the point where they achieve commercial payback
Three important trends associated with leading practices in other industries lessons are changing the way we do Research in Biopharma. These are
- moving beyond enterprise innovation to collaborative innovation
- moving from "block to fence" to 'block to play" IP strategy
- operating in a "make to perform" model, rather than "make to specification"
I am going to blog about each of the three over the coming weeks and highlight the leading examples.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment